First, it demonstrates the high variability of PSMA expression in non-prostatic tumor lesions and its dependency of the local tumor microenvironment (e.g., site of metastasis, neoangiogenetic activity, organ-specific perfusion effects). Here, FOLH1 is linked to neoplasm.